Sana lowered to market perform by JMP over data uncertainty
| SANA Stock | USD 1.69 0.22 11.52% |
About 63% of Sana Biotechnology's investor base is looking to short. The analysis of the overall investor sentiment regarding Sana Biotechnology suggests that many traders are alarmed. The current market sentiment, together with Sana Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Sana Biotechnology stock news signals to limit their universe of possible portfolio assets.
Sana |
JMP has downgraded Sana to market perform, citing uncertainty surrounding various data readouts following the companys pipeline reprioritization. Read more here.
Read at seekingalpha.com
 |
Sana Biotechnology Fundamental Analysis
We analyze Sana Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sana Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sana Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Sana Biotechnology is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Sana Biotechnology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sana Biotechnology stock to make a market-neutral strategy. Peer analysis of Sana Biotechnology could also be used in its relative valuation, which is a method of valuing Sana Biotechnology by comparing valuation metrics with similar companies.
Peers
Sana Biotechnology Related Equities
| LYEL | Lyell Immunopharma | 8.47 | ||||
| HOOK | Hookipa Pharma | 7.00 | ||||
| GBIO | Generation Bio | 5.88 | ||||
| TERN | Terns Pharmaceuticals | 5.03 | ||||
| RVMD | Revolution Medicines | 0.74 | ||||
| AMLX | Amylyx Pharmaceuticals | 0.51 | ||||
| DAWN | Day One | 0.56 | ||||
| OLMA | Olema Pharmaceuticals | 1.03 | ||||
| APLS | Apellis Pharmaceuticals | 1.48 | ||||
| BPMC | Blueprint Medicines | 3.11 | ||||
| NKTX | Nkarta | 4.41 | ||||
| XFOR | X4 Pharmaceuticals | 4.69 | ||||
| CGEM | Cullinan Oncology | 6.27 | ||||
| ZNTL | Zentalis Pharmaceuticals | 6.71 | ||||
| GLUE | Monte Rosa | 7.40 | ||||
| KYMR | Kymera Therapeutics | 7.66 |
Complementary Tools for Sana Stock analysis
When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |